BRAF and colorectal carcinoma: In addition to RAS pathway, although other study reported there were correlations between PD-L1 expression with BRAF mutation in CRC (Rosenbaum et al., 2016), so far we could not find any relationship of RAS/BRAF mutation with PD-L1 expression.